Ivett Gabriella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ivett Gabriella has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Karen Kathleen Szumlinski
Department of Psychological and Brain Sciences University of California Santa Barbara Santa Barbara California USA
2 shared publications Abinanda Mukundan
Stanley Laboratory, Department of Molecular, Cell and Systems Biology, University of California, Riverside, Riverside, CA, United States
1 shared publication- Andy Tseng
Graduate Program in Neuroscience, University of California Riverside, Riverside, CA 92521, USA
1 shared publication Aneerudh Venkatraghavan
Stanley Laboratory, Department of Molecular, Cell and Systems Biology, University of California, Riverside, Riverside, CA, United States
1 shared publication- Angie Laguna
Department of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93196-9660, USA
1 shared publication B. Glenn Stanley
Stanley Laboratory, Psychology Department, University of California, Riverside, Riverside, CA, United States
1 shared publication
Latest Publications
- Open Access
- 4 August 2025
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 19, 1633659
GABA receptor antagonism elicits feeding in the septohypothalamic nucleus
Introduction: Current rates of obesity and eating disorders have been steadily increasing, highlighting the importance of understanding the neural circuits of eating. This study explores the potential role of an understudied brain region, the septohypothalamic nucleus (SHy), in feeding control. Based on a serendipitous observation, we hypothesized that central injections of gamma-aminobutyric acid (GABA) receptor antagonists in the SHy would elicit feeding.Method: Adult male Sprague-Dawley rats (n = 39) were microinjected with a vehicle or GABAA receptor antagonists (bicuculline or picrotoxin) or a GABAB receptor antagonist (2-(S)-(+)-2-hydroxy-saclofen [2-OH saclofen]). Food and water intakes were measured at 1, 2, 3, and 24 h after injection, and behavioral responses (sleeping, resting, locomotor activity, vigorous activity, and grooming) were measured for 1 h.Result: Results showed increased food intake after bicuculline (p < 0.001) and picrotoxin (p = 0.03) injections during the 2nd and 3rd hours compared to controls. In addition, we found increased food intake 1 hour after 2-OH saclofen injections (p < 0.001). As for other behaviors, all three of the drugs suppressed resting (bicuculline: p < 0.001; picrotoxin: p < 0.001; 2-OH saclofen: p < 0.01) and increased locomotor activity (bicuculline: p < 0.001; picrotoxin: p < 0.001; 2-OH saclofen: p = 0.02).Discussion: Our findings suggest that GABAA or GABAB receptor deactivation by antagonists elicited eating with a delayed effect and increased general arousal in rats. These findings collectively suggest that SHy neurons expressing GABAA and/or GABAB receptors are elements of a neurocircuit that participates in the regulation of feeding.
- 4 August 2025
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 19, 1633659
Open AccessGABA receptor antagonism elicits feeding in the septohypothalamic nucleus
Introduction: Current rates of obesity and eating disorders have been steadily increasing, highlighting the importance of understanding the neural circuits of eating. This study explores the potential role of an understudied brain region, the septohypothalamic nucleus (SHy), in feeding control. Based on a serendipitous observation, we hypothesized that central injections of gamma-aminobutyric acid (GABA) receptor antagonists in the SHy would elicit feeding.Method: Adult male Sprague-Dawley rats (n = 39) were microinjected with a vehicle or GABAA receptor antagonists (bicuculline or picrotoxin) or a GABAB receptor antagonist (2-(S)-(+)-2-hydroxy-saclofen [2-OH saclofen]). Food and water intakes were measured at 1, 2, 3, and 24 h after injection, and behavioral responses (sleeping, resting, locomotor activity, vigorous activity, and grooming) were measured for 1 h.Result: Results showed increased food intake after bicuculline (p < 0.001) and picrotoxin (p = 0.03) injections during the 2nd and 3rd hours compared to controls. In addition, we found increased food intake 1 hour after 2-OH saclofen injections (p < 0.001). As for other behaviors, all three of the drugs suppressed resting (bicuculline: p < 0.001; picrotoxin: p < 0.001; 2-OH saclofen: p < 0.01) and increased locomotor activity (bicuculline: p < 0.001; picrotoxin: p < 0.001; 2-OH saclofen: p = 0.02).Discussion: Our findings suggest that GABAA or GABAB receptor deactivation by antagonists elicited eating with a delayed effect and increased general arousal in rats. These findings collectively suggest that SHy neurons expressing GABAA and/or GABAB receptors are elements of a neurocircuit that participates in the regulation of feeding.
- Open Access
- 28 June 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (7) , 848
Stimulation of GABA Receptors in the Lateral Septum Rapidly Elicits Food Intake and Mediates Natural Feeding
The increasing prevalence of obesity and eating disorders makes identifying neural substrates controlling eating and regulating body weight a priority. Recent studies have highlighted the role of the lateral septum (LS) in eating control mechanisms. The current study explored the roles of gamma-aminobutyric acid (GABA) receptors within the LS in the control of food intake. Experiments with a rat model (n ≥ 11/group) showed that LS microinjection of the GABAA receptor agonist, muscimol, and the GABAB receptor agonist, baclofen hydrochloride (baclofen), elicited intense, dose-dependent feeding. In contrast, LS pretreatment with the GABAA receptor antagonist, picrotoxin, markedly reduced the muscimol-elicited feeding, and pretreatment injections with the GABAB receptor antagonist, 2-hydroxysaclofen (2-OH saclofen), reduced the baclofen evoked response. Next, we showed that picrotoxin injection at the beginning of the dark phase of the light-dark cycle—when rats show a burst of spontaneous eating—reduced naturally occurring feeding, whereas 2-OH saclofen was ineffective. These results indicate that the activation of LS GABAA and GABAB receptors strongly stimulates feeding and suggests potential roles in feeding control neurocircuitry. In particular, our evidence indicates that endogenous LS GABA and GABAA receptors may be involved in mediating naturally occurring nocturnal feeding.
- 28 June 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (7) , 848
Open AccessStimulation of GABA Receptors in the Lateral Septum Rapidly Elicits Food Intake and Mediates Natural Feeding
The increasing prevalence of obesity and eating disorders makes identifying neural substrates controlling eating and regulating body weight a priority. Recent studies have highlighted the role of the lateral septum (LS) in eating control mechanisms. The current study explored the roles of gamma-aminobutyric acid (GABA) receptors within the LS in the control of food intake. Experiments with a rat model (n ≥ 11/group) showed that LS microinjection of the GABAA receptor agonist, muscimol, and the GABAB receptor agonist, baclofen hydrochloride (baclofen), elicited intense, dose-dependent feeding. In contrast, LS pretreatment with the GABAA receptor antagonist, picrotoxin, markedly reduced the muscimol-elicited feeding, and pretreatment injections with the GABAB receptor antagonist, 2-hydroxysaclofen (2-OH saclofen), reduced the baclofen evoked response. Next, we showed that picrotoxin injection at the beginning of the dark phase of the light-dark cycle—when rats show a burst of spontaneous eating—reduced naturally occurring feeding, whereas 2-OH saclofen was ineffective. These results indicate that the activation of LS GABAA and GABAB receptors strongly stimulates feeding and suggests potential roles in feeding control neurocircuitry. In particular, our evidence indicates that endogenous LS GABA and GABAA receptors may be involved in mediating naturally occurring nocturnal feeding.
- Open Access
- 26 June 2020
- Published by MDPI AG in Brain Sciences
- Vol. 10 (6) , 405
Incubation of Negative Affect during Protracted Alcohol Withdrawal Is Age-, but Not Sex-Selective
A prior history of excessive drinking induces a negative affective state in both humans and laboratory rodents, the manifestation of which varies with the age of drinking-onset. In adolescent male mice, negative affect incubates over the course of a 30-day alcohol withdrawal period. In contrast, the negative affect exhibited by adult male mice is robust at 1 day withdrawal, but dissipates with the passage of time. As females tend to consume more alcohol than males, we aimed to explore the affective disturbances exhibited by adolescent and adult C57BL/6J mice of both sexes during more protracted alcohol withdrawal and to relate any behavioral changes observed to plasma corticosterone levels as a biochemical index of stress. Male and female, adolescent and adult, mice were subjected to 14 consecutive days of binge alcohol-drinking using a multi-bottle-choice Drinking-in-the-Dark (DID) procedure (5, 10, 20 and 40% v/v). Age- and sex-matched control mice consumed water only. On either withdrawal day 1 or 70, subgroups of animals were subjected a to 1-day behavioral test battery that included the light–dark box shuttle test, marble-burying test, and Porsolt forced swim test. As expected, adolescent mice consumed more alcohol than adults and females consumed more alcohol than males. However, despite binge-like levels of alcohol consumption, we detected relatively few signs of alcohol withdrawal-induced negative affect and there was no correlation between affective behavior and circulating corticosterone levels. We discuss these findings within the context of our published work, highlighting procedural differences that might account for the relatively weak effect of binge-drinking history upon anxiety and depressive-like behavior observed herein.
- 26 June 2020
- Published by MDPI AG in Brain Sciences
- Vol. 10 (6) , 405
Open AccessIncubation of Negative Affect during Protracted Alcohol Withdrawal Is Age-, but Not Sex-Selective
A prior history of excessive drinking induces a negative affective state in both humans and laboratory rodents, the manifestation of which varies with the age of drinking-onset. In adolescent male mice, negative affect incubates over the course of a 30-day alcohol withdrawal period. In contrast, the negative affect exhibited by adult male mice is robust at 1 day withdrawal, but dissipates with the passage of time. As females tend to consume more alcohol than males, we aimed to explore the affective disturbances exhibited by adolescent and adult C57BL/6J mice of both sexes during more protracted alcohol withdrawal and to relate any behavioral changes observed to plasma corticosterone levels as a biochemical index of stress. Male and female, adolescent and adult, mice were subjected to 14 consecutive days of binge alcohol-drinking using a multi-bottle-choice Drinking-in-the-Dark (DID) procedure (5, 10, 20 and 40% v/v). Age- and sex-matched control mice consumed water only. On either withdrawal day 1 or 70, subgroups of animals were subjected a to 1-day behavioral test battery that included the light–dark box shuttle test, marble-burying test, and Porsolt forced swim test. As expected, adolescent mice consumed more alcohol than adults and females consumed more alcohol than males. However, despite binge-like levels of alcohol consumption, we detected relatively few signs of alcohol withdrawal-induced negative affect and there was no correlation between affective behavior and circulating corticosterone levels. We discuss these findings within the context of our published work, highlighting procedural differences that might account for the relatively weak effect of binge-drinking history upon anxiety and depressive-like behavior observed herein.
- 6 September 2019
- Published by Wiley in Genes, Brain and Behavior
- Vol. 19 (5) , e12609
Who is HOT and who is LOT? Detailed characterization of prescription opioid‐induced changes in behavior between 129P3/J and 129S1/SvlmJ mouse substrains
Genetic factors are theorized to contribute to the substantial inter‐individual variability in opioid abuse/addiction. To advance the behavioral genetics of prescription opioid abuse, our prior work identified the 129S1/SvlmJ (S1) and related 129P3/J (P3) mouse substrains, respectively, as low and high opioid‐taking. Herein, we related our prior results to measures of sucrose reward/reinforcement, basal anxiety, opioid‐induced place‐conditioning, locomotor activity and Straub tail reaction, as well as behavioral and physiological signs of withdrawal. Substrains were also re‐examined for higher‐dose oxycodone and fentanyl intake under limited‐access drinking procedures. S1 mice failed to acquire sucrose self‐administration under various operant‐conditioning procedures and exhibited lower sucrose intake in the home‐cage. However, sucrose intake under limited‐access procedures escalated in both substrains with repeated sucrose experience. S1 mice exhibited less spontaneous locomotor activity, as well as less opioid‐induced locomotor activity and Straub tail reaction, than P3 mice and failed to exhibit an oxycodone‐induced place‐preference. The lack of conditioned behavior by S1 mice was unrelated to behavioral signs of withdrawal‐induced negative affect or dependence severity, but might reflect high levels of basal anxiety‐like behavior. Intriguingly, S1 and P3 mice initially exhibited equivalent oxycodone and fentanyl consumption in the home‐cage; however opioid intake escalated only in P3 mice with repeated opioid experience. No sex differences were observed for any of our measures. These data provide additional evidence for robust differences in opioid addiction‐related behaviors between P3 and S1 substrains and suggest that anxiety, learning, and/or motivational impairments might confound interpretation of operant‐ and place‐conditioning studies employing the S1 substrain.
- 6 September 2019
- Published by Wiley in Genes, Brain and Behavior
- Vol. 19 (5) , e12609
Who is HOT and who is LOT? Detailed characterization of prescription opioid‐induced changes in behavior between 129P3/J and 129S1/SvlmJ mouse substrains
Genetic factors are theorized to contribute to the substantial inter‐individual variability in opioid abuse/addiction. To advance the behavioral genetics of prescription opioid abuse, our prior work identified the 129S1/SvlmJ (S1) and related 129P3/J (P3) mouse substrains, respectively, as low and high opioid‐taking. Herein, we related our prior results to measures of sucrose reward/reinforcement, basal anxiety, opioid‐induced place‐conditioning, locomotor activity and Straub tail reaction, as well as behavioral and physiological signs of withdrawal. Substrains were also re‐examined for higher‐dose oxycodone and fentanyl intake under limited‐access drinking procedures. S1 mice failed to acquire sucrose self‐administration under various operant‐conditioning procedures and exhibited lower sucrose intake in the home‐cage. However, sucrose intake under limited‐access procedures escalated in both substrains with repeated sucrose experience. S1 mice exhibited less spontaneous locomotor activity, as well as less opioid‐induced locomotor activity and Straub tail reaction, than P3 mice and failed to exhibit an oxycodone‐induced place‐preference. The lack of conditioned behavior by S1 mice was unrelated to behavioral signs of withdrawal‐induced negative affect or dependence severity, but might reflect high levels of basal anxiety‐like behavior. Intriguingly, S1 and P3 mice initially exhibited equivalent oxycodone and fentanyl consumption in the home‐cage; however opioid intake escalated only in P3 mice with repeated opioid experience. No sex differences were observed for any of our measures. These data provide additional evidence for robust differences in opioid addiction‐related behaviors between P3 and S1 substrains and suggest that anxiety, learning, and/or motivational impairments might confound interpretation of operant‐ and place‐conditioning studies employing the S1 substrain.